
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux... Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.71 | 1.71 | 1.71 | 0 | 0 | CS |
4 | 0 | 0 | 1.71 | 1.71 | 1.71 | 0 | 0 | CS |
12 | -2.18 | -56.0411311054 | 3.89 | 3.95 | 1.35 | 14499 | 2.14925105 | CS |
26 | -4.23 | -71.2121212121 | 5.94 | 11.685 | 1.35 | 5928340 | 6.99376381 | CS |
52 | -25.89 | -93.8043478261 | 27.6 | 32.4 | 1.35 | 3229362 | 7.20652912 | CS |
156 | -398.79 | -99.5730337079 | 400.5 | 414.99 | 1.35 | 1181163 | 28.98958281 | CS |
260 | -3017.79 | -99.9433681073 | 3019.5 | 3285 | 1.35 | 1262580 | 895.02300692 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions